{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T09:12:24Z","timestamp":1779268344048,"version":"3.51.4"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-73120-1","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T09:03:33Z","timestamp":1779267813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multivalent nanobodies for potent and broad neutralization of Staphylococcus aureus toxins"],"prefix":"10.1038","volume":"17","author":[{"given":"Yong Joon Jeffrey","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5345-4550","authenticated-orcid":false,"given":"Nicholas R.","family":"Walton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madison","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufei","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Sang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaya","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2203-6568","authenticated-orcid":false,"given":"Sarah K. L.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9932-1856","authenticated-orcid":false,"given":"Derek J.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6630-0060","authenticated-orcid":false,"given":"Jaime L.","family":"Hook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3742-7289","authenticated-orcid":false,"given":"John K.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2761-8324","authenticated-orcid":false,"given":"Yi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"73120_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S1473-3099(18)30648-0","volume":"19","author":"E Tacconelli","year":"2019","unstructured":"Tacconelli, E. & Pezzani, M. D. Public health burden of antimicrobial resistance in Europe. Lancet Infect. Dis. 19, 4\u20136 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"73120_CR2","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","volume":"400","author":"GBDAR Collaborators","year":"2022","unstructured":"Collaborators, G. B. D. A. R. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 400, 2221\u20132248 (2022).","journal-title":"Lancet"},{"key":"73120_CR3","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"GBDAR Collaborators","year":"2024","unstructured":"Collaborators, G. B. D. A. R. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Lancet. 404, 1199\u20131226 (2024).","journal-title":"Lancet"},{"key":"73120_CR4","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.3389\/fmicb.2018.02419","volume":"9","author":"A Sakr","year":"2018","unstructured":"Sakr, A., Bregeon, F., Mege, J. L., Rolain, J. M. & Blin, O. Staphylococcus aureus nasal colonization: an update on mechanisms, epidemiology, risk factors, and subsequent infections. Front Microbiol. 9, 2419 (2018).","journal-title":"Front Microbiol"},{"key":"73120_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1128\/CMR.10.3.505","volume":"10","author":"J Kluytmans","year":"1997","unstructured":"Kluytmans, J., van Belkum, A. & Verbrugh, H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 10, 505\u2013520 (1997).","journal-title":"Clin. Microbiol. Rev."},{"key":"73120_CR6","doi-asserted-by":"publisher","first-page":"373S","DOI":"10.1378\/chest.119.2_suppl.373S","volume":"119","author":"JP Lynch","year":"2001","unstructured":"Lynch, J. P. 3rd, hospital-acquired pneumonia: risk factors, microbiology, and treatment. Chest 119, 373S\u2013384S (2001).","journal-title":"Chest"},{"key":"73120_CR7","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1378\/chest.128.6.3854","volume":"128","author":"MH Kollef","year":"2005","unstructured":"Kollef, M. H. et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128, 3854\u20133862 (2005).","journal-title":"Chest"},{"key":"73120_CR8","doi-asserted-by":"crossref","unstructured":"M. S. Linz, A. Mattappallil, D. Finkel, D. Parker, Clinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections. Antibiotics. 12, 557 (2023).","DOI":"10.3390\/antibiotics12030557"},{"key":"73120_CR9","doi-asserted-by":"crossref","unstructured":"K. L. Urish, J. E. Cassat, Staphylococcus aureus osteomyelitis: bone, bugs, and surgery. Infect Immun 88, e00932\u201319 (2020).","DOI":"10.1128\/IAI.00932-19"},{"key":"73120_CR10","unstructured":"CDC, Antimicrobial Resistance Threats in the United States, 2021\u20132022. (2024)."},{"key":"73120_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro2200","volume":"7","author":"HF Chambers","year":"2009","unstructured":"Chambers, H. F. & Deleo, F. R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7, 629\u2013641 (2009).","journal-title":"Nat. Rev. Microbiol"},{"key":"73120_CR12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1093\/femsre\/fux007","volume":"41","author":"TJ Foster","year":"2017","unstructured":"Foster, T. J. Antibiotic resistance in Staphylococcus aureus. Current status and future prospects. FEMS Microbiol. Rev. 41, 430\u2013449 (2017).","journal-title":"FEMS Microbiol. Rev."},{"key":"73120_CR13","doi-asserted-by":"crossref","unstructured":"R. R. Watkins, M. Holubar, M. Z. David. Antimicrobial resistance in methicillin-resistant Staphylococcus aureus to newer antimicrobial agents. Antimicrob Agents Chemother 63, e01216\u201319 (2019).","DOI":"10.1128\/AAC.01216-19"},{"key":"73120_CR14","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.chembiol.2022.04.003","volume":"29","author":"CM Tsai","year":"2022","unstructured":"Tsai, C. M., Hajam, I. A., Caldera, J. R. & Liu, G. Y. Integrating complex host-pathogen immune environments into S. aureus vaccine studies. Cell Chem. Biol. 29, 730\u2013740 (2022).","journal-title":"Cell Chem. Biol."},{"key":"73120_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101360","volume":"5","author":"JR Caldera","year":"2024","unstructured":"Caldera, J. R. et al. The characteristics of pre-existing humoral imprint determine the efficacy of S. aureus vaccines and support alternative vaccine approaches. Cell Rep. Med. 5, 101360 (2024).","journal-title":"Cell Rep. Med."},{"key":"73120_CR16","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.chom.2022.06.006","volume":"30","author":"CM Tsai","year":"2022","unstructured":"Tsai, C. M. et al. Non-protective immune imprint underlies failure of Staphylococcus aureus IsdB vaccine. Cell Host Microbe 30, 1163\u20131172 e1166 (2022).","journal-title":"Cell Host Microbe"},{"key":"73120_CR17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/21505594.2021.1878688","volume":"12","author":"GYC Cheung","year":"2021","unstructured":"Cheung, G. Y. C., Bae, J. S. & Otto, M. Pathogenicity and virulence of Staphylococcus aureus. Virulence 12, 547\u2013569 (2021).","journal-title":"Virulence"},{"key":"73120_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41577-023-00979-2","volume":"24","author":"SW Tuffs","year":"2024","unstructured":"Tuffs, S. W., Dufresne, K., Rishi, A., Walton, N. R. & McCormick, J. K. Novel insights into the immune response to bacterial T cell superantigens. Nat. Rev. Immunol. 24, 417\u2013434 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"73120_CR19","doi-asserted-by":"crossref","unstructured":"D. Lefebvre et al. Multiplex detection of 24 staphylococcal enterotoxins in culture supernatant using liquid chromatography coupled to high-resolution mass spectrometry. Toxins 14, 249 (2022).","DOI":"10.3390\/toxins14040249"},{"key":"73120_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev.micro.55.1.77","volume":"55","author":"JK McCormick","year":"2001","unstructured":"McCormick, J. K., Yarwood, J. M. & Schlievert, P. M. Toxic shock syndrome and bacterial superantigens: an update. Annu Rev. Microbiol. 55, 77\u2013104 (2001).","journal-title":"Annu Rev. Microbiol."},{"key":"73120_CR21","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1128\/CMR.00104-12","volume":"26","author":"AR Spaulding","year":"2013","unstructured":"Spaulding, A. R. et al. Staphylococcal and streptococcal superantigen exotoxins. Clin. Microbiol Rev. 26, 422\u2013447 (2013).","journal-title":"Clin. Microbiol Rev."},{"key":"73120_CR22","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.micres.2013.03.004","volume":"168","author":"S Enany","year":"2013","unstructured":"Enany, S. et al. Two-dimensional electrophoresis of the exo-proteome produced from community-acquired methicillin-resistant Staphylococcus aureus belonging to clonal complex 80. Microbiol Res. 168, 504\u2013511 (2013).","journal-title":"Microbiol Res."},{"key":"73120_CR23","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1128\/CMR.00120-16","volume":"30","author":"E Hodille","year":"2017","unstructured":"Hodille, E. et al. The role of antibiotics in modulating virulence in Staphylococcus aureus. Clin. Microbiol Rev. 30, 887\u2013917 (2017).","journal-title":"Clin. Microbiol Rev."},{"key":"73120_CR24","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/10408419009105728","volume":"17","author":"GA Bohach","year":"1990","unstructured":"Bohach, G. A., Fast, D. J., Nelson, R. D. & Schlievert, P. M. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit. Rev. Microbiol 17, 251\u2013272 (1990).","journal-title":"Crit. Rev. Microbiol"},{"key":"73120_CR25","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1093\/infdis\/jiaa584","volume":"223","author":"JS Bae","year":"2021","unstructured":"Bae, J. S. et al. Contribution of staphylococcal enterotoxin B to Staphylococcus aureus systemic infection. J. Infect. Dis. 223, 1766\u20131775 (2021).","journal-title":"J. Infect. Dis."},{"key":"73120_CR26","doi-asserted-by":"crossref","unstructured":"King, J. M., Kulhankova, K., Stach, C. S., Vu, B. G., Salgado-Pabon, W. Phenotypes and virulence among Staphylococcus aureus USA100, USA200, USA300, USA400, and USA600 Clonal Lineages. mSphere 1, e00071\u201316 (2016).","DOI":"10.1128\/mSphere.00071-16"},{"key":"73120_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1008052","volume":"13","author":"R Zhao","year":"2022","unstructured":"Zhao, R. et al. Molecular characterization and virulence gene profiling of methicillin-resistant Staphylococcus aureus associated with bloodstream infections in southern China. Front. Microbiol. 13, 1008052 (2022).","journal-title":"Front. Microbiol."},{"key":"73120_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2014.03.009","volume":"79","author":"JW Chung","year":"2014","unstructured":"Chung, J. W. et al. Superantigen profiling of Staphylococcus aureus infective endocarditis isolates. Diagn. Microbiol. Infect. Dis. 79, 119\u2013124 (2014).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"73120_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo1072","volume":"8","author":"KJ Kinney","year":"2022","unstructured":"Kinney, K. J. et al. SEC is an antiangiogenic virulence factor that promotes Staphylococcus aureus endocarditis independent of superantigen activity. Sci. Adv. 8, eabo1072 (2022).","journal-title":"Sci. Adv."},{"key":"73120_CR30","doi-asserted-by":"crossref","unstructured":"Etter D., Schelin, J., Schuppler, M., Johler S. Staphylococcal enterotoxin C-an update on SEC variants, their structure and properties, and their role in foodborne intoxications. Toxins. 12, 584 (2020).","DOI":"10.3390\/toxins12090584"},{"key":"73120_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/protein\/gzs094","volume":"26","author":"DM Mattis","year":"2013","unstructured":"Mattis, D. M. et al. Engineering a soluble high-affinity receptor domain that neutralizes staphylococcal enterotoxin C in rabbit models of disease. Protein Eng. Des. Sel. 26, 133\u2013142 (2013).","journal-title":"Protein Eng. Des. Sel."},{"key":"73120_CR32","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1084\/jem.172.3.981","volume":"172","author":"Y Choi","year":"1990","unstructured":"Choi, Y. et al. Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J. Exp. Med. 172, 981\u2013984 (1990).","journal-title":"J. Exp. Med."},{"key":"73120_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0065-2776(08)60534-9","volume":"54","author":"BL Kotzin","year":"1993","unstructured":"Kotzin, B. L., Leung, D. Y., Kappler, J. & Marrack, P. Superantigens and their potential role in human disease. Adv. Immunol. 54, 99\u2013166 (1993).","journal-title":"Adv. Immunol."},{"key":"73120_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.semcdb.2017.04.003","volume":"72","author":"ES Seilie","year":"2017","unstructured":"Seilie, E. S. & Bubeck Wardenburg, J. Staphylococcus aureus pore-forming toxins: the interface of pathogen and host complexity. Semin Cell Dev. Biol. 72, 101\u2013116 (2017).","journal-title":"Semin Cell Dev. Biol."},{"key":"73120_CR35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev-immunol-030409-101253","volume":"28","author":"MK Jenkins","year":"2010","unstructured":"Jenkins, M. K., Chu, H. H., McLachlan, J. B. & Moon, J. J. On the composition of the preimmune repertoire of T cells specific for Peptide-major histocompatibility complex ligands. Annu Rev. Immunol. 28, 275\u2013294 (2010).","journal-title":"Annu Rev. Immunol."},{"key":"73120_CR36","doi-asserted-by":"crossref","unstructured":"Dan J. M. et al. Recurrent group A Streptococcus tonsillitis is an immunosusceptibility disease involving antibody deficiency and aberrant T(FH) cells. Sci. Transl. Med. 11, eaau3776 (2019).","DOI":"10.1126\/scitranslmed.aau3776"},{"key":"73120_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/cei.13282","volume":"197","author":"FJ Davies","year":"2019","unstructured":"Davies, F. J., Olme, C., Lynskey, N. N., Turner, C. E. & Sriskandan, S. Streptococcal superantigen-induced expansion of human tonsil T cells leads to altered T follicular helper cell phenotype, B cell death and reduced immunoglobulin release. Clin. Exp. Immunol. 197, 83\u201394 (2019).","journal-title":"Clin. Exp. Immunol."},{"key":"73120_CR38","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3390\/toxins5061140","volume":"5","author":"BJ Berube","year":"2013","unstructured":"Berube, B. J. & Wardenburg, J. B. ubeck Staphylococcus aureus alpha-toxin: nearly a century of intrigue. Toxins 5, 1140\u20131166 (2013).","journal-title":"Toxins"},{"key":"73120_CR39","doi-asserted-by":"crossref","unstructured":"Oliveira, D., Borges, A., Simoes, M. Staphylococcus aureus toxins and their molecular activity in infectious diseases. Toxins. 10, 252 (2018).","DOI":"10.3390\/toxins10060252"},{"key":"73120_CR40","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.1128\/AAC.00357-16","volume":"60","author":"DE Tabor","year":"2016","unstructured":"Tabor, D. E. et al. Staphylococcus aureus alpha-toxin is conserved among diverse hospital respiratory isolates collected from a global surveillance study and is neutralized by monoclonal antibody MEDI4893. Antimicrob. Agents Chemother. 60, 5312\u20135321 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"73120_CR41","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.chom.2015.05.011","volume":"17","author":"ME Powers","year":"2015","unstructured":"Powers, M. E., Becker, R. E., Sailer, A., Turner, J. R. & Bubeck Wardenburg, J. Synergistic action of Staphylococcus aureus alpha-toxin on platelets and myeloid lineage cells contributes to lethal sepsis. Cell Host Microbe 17, 775\u2013787 (2015).","journal-title":"Cell Host Microbe"},{"key":"73120_CR42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.chom.2018.06.017","volume":"24","author":"BGJ Surewaard","year":"2018","unstructured":"Surewaard, B. G. J. et al. Alpha-toxin induces platelet aggregation and liver injury during Staphylococcus aureus sepsis. Cell Host Microbe 24, 271\u2013284 e273 (2018).","journal-title":"Cell Host Microbe"},{"key":"73120_CR43","doi-asserted-by":"crossref","unstructured":"Diep, B. A. et al. Targeting alpha toxin to mitigate its lethal toxicity in ferret and rabbit models of Staphylococcus aureus necrotizing pneumonia. Antimicrob Agents Chemother 61, e02456\u201316 (2017).","DOI":"10.1128\/AAC.02456-16"},{"key":"73120_CR44","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.1128\/IAI.67.10.5541-5544.1999","volume":"67","author":"MC McElroy","year":"1999","unstructured":"McElroy, M. C. et al. Alpha-toxin damages the air-blood barrier of the lung in a rat model of Staphylococcus aureus-induced pneumonia. Infect. Immun. 67, 5541\u20135544 (1999).","journal-title":"Infect. Immun."},{"key":"73120_CR45","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1086\/592758","volume":"198","author":"AH Bartlett","year":"2008","unstructured":"Bartlett, A. H., Foster, T. J., Hayashida, A. & Park, P. W. Alpha-toxin facilitates the generation of CXC chemokine gradients and stimulates neutrophil homing in Staphylococcus aureus pneumonia. J. Infect. Dis. 198, 1529\u20131535 (2008).","journal-title":"J. Infect. Dis."},{"key":"73120_CR46","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1128\/mr.55.4.733-751.1991","volume":"55","author":"S Bhakdi","year":"1991","unstructured":"Bhakdi, S. & Tranum-Jensen, J. Alpha-toxin of Staphylococcus aureus. Microbiol. Rev. 55, 733\u2013751 (1991).","journal-title":"Microbiol. Rev."},{"key":"73120_CR47","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1172\/JCI95823","volume":"128","author":"JL Hook","year":"2018","unstructured":"Hook, J. L. et al. Disruption of staphylococcal aggregation protects against lethal lung injury. J. Clin. Investig. 128, 1074\u20131086 (2018).","journal-title":"J. Clin. Investig."},{"key":"73120_CR48","doi-asserted-by":"publisher","first-page":"13473","DOI":"10.1073\/pnas.1001815107","volume":"107","author":"GA Wilke","year":"2010","unstructured":"Wilke, G. A. & Wardenburg, J. B. Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury. Proc. Natl. Acad. Sci. USA 107, 13473\u201313478 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73120_CR49","doi-asserted-by":"publisher","first-page":"ra331","DOI":"10.1126\/scitranslmed.aad9922","volume":"8","author":"TS Cohen","year":"2016","unstructured":"Cohen, T. S. et al. Staphylococcus aureus alpha toxin potentiates opportunistic bacterial lung infections. Sci. Transl. Med. 8, ra331 (2016).","journal-title":"Sci. Transl. Med."},{"key":"73120_CR50","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1128\/CMR.13.1.16","volume":"13","author":"MM Dinges","year":"2000","unstructured":"Dinges, M. M., Orwin, P. M. & Schlievert, P. M. Exotoxins of Staphylococcus aureus. Clin. Microbiol Rev. 13, 16\u201334 (2000).","journal-title":"Clin. Microbiol Rev."},{"key":"73120_CR51","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fcimb.2012.00064","volume":"2","author":"MJ Anderson","year":"2012","unstructured":"Anderson, M. J. et al. Alpha-toxin promotes Staphylococcus aureus mucosal biofilm formation. Front Cell Infect. Microbiol. 2, 64 (2012).","journal-title":"Front Cell Infect. Microbiol"},{"key":"73120_CR52","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","volume":"82","author":"S Muyldermans","year":"2013","unstructured":"Muyldermans, S. Nanobodies: natural single-domain antibodies. Annu Rev. Biochem 82, 775\u2013797 (2013).","journal-title":"Annu Rev. Biochem"},{"key":"73120_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114726","volume":"195","author":"J Yong Joon Kim","year":"2023","unstructured":"Yong Joon Kim, J., Sang, Z., Xiang, Y., Shen, Z. & Shi, Y. Nanobodies: robust miniprotein binders in biomedicine. Adv. Drug Deliv. Rev. 195, 114726 (2023).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"73120_CR54","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1126\/science.abe4747","volume":"370","author":"Y Xiang","year":"2020","unstructured":"Xiang, Y. et al. Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2. Science 370, 1479\u20131484 (2020).","journal-title":"Science"},{"key":"73120_CR55","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.cels.2021.01.003","volume":"12","author":"Y Xiang","year":"2021","unstructured":"Xiang, Y. et al. Integrative proteomics identifies thousands of distinct, multi-epitope, and high-affinity nanobodies. Cell Syst. 12, 220\u2013234 e229 (2021).","journal-title":"Cell Syst."},{"key":"73120_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111004","volume":"39","author":"Y Xiang","year":"2022","unstructured":"Xiang, Y. et al. Superimmunity by pan-sarbecovirus nanobodies. Cell Rep. 39, 111004 (2022).","journal-title":"Cell Rep."},{"key":"73120_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24963-3","volume":"12","author":"D Sun","year":"2021","unstructured":"Sun, D. et al. Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes. Nat. Commun. 12, 4676 (2021).","journal-title":"Nat. Commun."},{"key":"73120_CR58","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.str.2025.01.019","volume":"33","author":"NE Ketaren","year":"2025","unstructured":"Ketaren, N. E. et al. Unique mechanisms to increase structural stability and enhance antigen binding in nanobodies. Structure 33, 677\u2013690 e675 (2025).","journal-title":"Structure"},{"key":"73120_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100745","volume":"296","author":"IA Wilson","year":"2021","unstructured":"Wilson, I. A. & Stanfield, R. L. 50 Years of structural immunology. J. Biol. Chem. 296, 100745 (2021).","journal-title":"J. Biol. Chem."},{"key":"73120_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35642-2","volume":"13","author":"M Li","year":"2022","unstructured":"Li, M. et al. Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4\/5 and diverse sarbecoviruses. Nat. Commun. 13, 7957 (2022).","journal-title":"Nat. Commun."},{"key":"73120_CR61","doi-asserted-by":"crossref","unstructured":"Z. Sang et al. Repertoire-scale antibody structural prediction informstherapeutic design. Sci Adv, 12, eaef7163 (2026).","DOI":"10.1126\/sciadv.aef7163"},{"key":"73120_CR62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40259-019-00392-z","volume":"34","author":"I Jovcevska","year":"2020","unstructured":"Jovcevska, I. & Muyldermans, S. The therapeutic potential of nanobodies. BioDrugs 34, 11\u201326 (2020).","journal-title":"BioDrugs"},{"key":"73120_CR63","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.molmed.2022.08.007","volume":"28","author":"Z Shen","year":"2022","unstructured":"Shen, Z., Sang, Z. & Shi, Y. Nanobodies as a powerful platform for biomedicine. Trends Mol. Med. 28, 1006\u20131007 (2022).","journal-title":"Trends Mol. Med."},{"key":"73120_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100865","volume":"23","author":"PC Fridy","year":"2024","unstructured":"Fridy, P. C., Rout, M. P. & Ketaren, N. E. Nanobodies: from high-throughput identification to therapeutic development. Mol. Cell Proteom. 23, 100865 (2024).","journal-title":"Mol. Cell Proteom."},{"key":"73120_CR65","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.str.2021.11.006","volume":"30","author":"Z Sang","year":"2022","unstructured":"Sang, Z., Xiang, Y., Bahar, I. & Shi, Y. Llamanade: an open-source computational pipeline for robust nanobody humanization. Structure 30, 418\u2013429 e413 (2022).","journal-title":"Structure"},{"key":"73120_CR66","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/SHK.0b013e3181cdc556","volume":"34","author":"WJ Brummelhuis","year":"2010","unstructured":"Brummelhuis, W. J. et al. Llama heavy-chain antibody fragments efficiently remove toxic shock syndrome toxin 1 from plasma in vitro but not in experimental porcine septic shock. Shock 34, 125\u2013132 (2010).","journal-title":"Shock"},{"key":"73120_CR67","doi-asserted-by":"crossref","unstructured":"A. C. Hughes et al. Development of thermally stable nanobodies for detection and neutralization of staphylococcal enterotoxin B. Toxins. 15, 400 (2023).","DOI":"10.3390\/toxins15060400"},{"key":"73120_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.126822","volume":"253","author":"K Ming","year":"2023","unstructured":"Ming, K. et al. Development of nanobodies against Staphylococcus enterotoxin B through yeast surface display. Int J. Biol. Macromol. 253, 126822 (2023).","journal-title":"Int J. Biol. Macromol."},{"key":"73120_CR69","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s42003-021-02357-x","volume":"4","author":"S Kumar","year":"2021","unstructured":"Kumar, S. et al. Structural basis of inhibition of a transporter from Staphylococcus aureus, NorC, through a single-domain camelid antibody. Commun. Biol. 4, 836 (2021).","journal-title":"Commun. Biol."},{"key":"73120_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104927","volume":"299","author":"S Valenciano-Bellido","year":"2023","unstructured":"Valenciano-Bellido, S. et al. Targeting hemoglobin receptors IsdH and IsdB of Staphylococcus aureus with a single VHH antibody inhibits bacterial growth. J. Biol. Chem. 299, 104927 (2023).","journal-title":"J. Biol. Chem."},{"key":"73120_CR71","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1128\/iai.62.6.2249-2256.1994","volume":"62","author":"R Jursch","year":"1994","unstructured":"Jursch, R. et al. Histidine residues near the N terminus of staphylococcal alpha-toxin as reporters of regions that are critical for oligomerization and pore formation. Infect. Immun. 62, 2249\u20132256 (1994).","journal-title":"Infect. Immun."},{"key":"73120_CR72","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1128\/iai.64.5.1839-1841.1996","volume":"64","author":"BE Menzies","year":"1996","unstructured":"Menzies, B. E. & Kernodle, D. S. Passive immunization with antiserum to a nontoxic alpha-toxin mutant from Staphylococcus aureus is protective in a murine model. Infect. Immun. 64, 1839\u20131841 (1996).","journal-title":"Infect. Immun."},{"key":"73120_CR73","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1128\/IAI.00920-08","volume":"77","author":"X Liang","year":"2009","unstructured":"Liang, X., Yan, M. & Ji, Y. The H35A mutated alpha-toxin interferes with cytotoxicity of staphylococcal alpha-toxin. Infect. Immun. 77, 977\u2013983 (2009).","journal-title":"Infect. Immun."},{"key":"73120_CR74","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/S0264-410X(01)00470-4","volume":"20","author":"J Gampfer","year":"2002","unstructured":"Gampfer, J., Thon, V., Gulle, H., Wolf, H. M. & Eibl, M. M. Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome. Vaccine 20, 1354\u20131364 (2002).","journal-title":"Vaccine"},{"key":"73120_CR75","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1110\/ps.39702","volume":"11","author":"HI Krupka","year":"2002","unstructured":"Krupka, H. I. et al. Structural basis for abrogated binding between staphylococcal enterotoxin A superantigen vaccine and MHC-IIalpha. Protein Sci. 11, 642\u2013651 (2002).","journal-title":"Protein Sci."},{"key":"73120_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39890-z","volume":"9","author":"A Venkatasubramaniam","year":"2019","unstructured":"Venkatasubramaniam, A. et al. TBA(225), a fusion toxoid vaccine for protection and broad neutralization of staphylococcal superantigens. Sci. Rep. 9, 3279 (2019).","journal-title":"Sci. Rep."},{"key":"73120_CR77","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1128\/CVI.00399-16","volume":"23","author":"WH Chen","year":"2016","unstructured":"Chen, W. H. et al. Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax. Clin. Vaccin. Immunol. 23, 918\u2013925 (2016).","journal-title":"Clin. Vaccin. Immunol."},{"key":"73120_CR78","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1128\/IAI.73.1.174-180.2005","volume":"73","author":"DL Hu","year":"2005","unstructured":"Hu, D. L. et al. A mutant of staphylococcal enterotoxin C devoid of bacterial superantigenic activity elicits a Th2 immune response for protection against Staphylococcus aureus infection. Infect. Immun. 73, 174\u2013180 (2005).","journal-title":"Infect. Immun."},{"key":"73120_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102404","volume":"67","author":"C Schoergenhofer","year":"2024","unstructured":"Schoergenhofer, C. et al. A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 results. EClinicalMedicine 67, 102404 (2024).","journal-title":"EClinicalMedicine"},{"key":"73120_CR80","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"73120_CR81","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/cid\/ciad218","volume":"77","author":"H Hassanzadeh","year":"2023","unstructured":"Hassanzadeh, H. et al. Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial. Clin. Infect. Dis. 77, 312\u2013320 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"73120_CR82","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.4161\/hv.21872","volume":"8","author":"AS Anderson","year":"2012","unstructured":"Anderson, A. S. et al. Development of a multicomponent Staphylococcus aureus vaccine designed to counter multiple bacterial virulence factors. Hum. Vaccin Immunother. 8, 1585\u20131594 (2012).","journal-title":"Hum. Vaccin Immunother."},{"key":"73120_CR83","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1056\/NEJMoa011297","volume":"346","author":"H Shinefield","year":"2002","unstructured":"Shinefield, H. et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N. Engl. J. Med. 346, 491\u2013496 (2002).","journal-title":"N. Engl. J. Med"},{"key":"73120_CR84","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1001\/jama.2013.3010","volume":"309","author":"VG Fowler","year":"2013","unstructured":"Fowler, V. G. et al. Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial. JAMA 309, 1368\u20131378 (2013).","journal-title":"JAMA"},{"key":"73120_CR85","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1128\/CVI.00034-12","volume":"19","author":"M Moustafa","year":"2012","unstructured":"Moustafa, M. et al. Phase IIa study of the immunogenicity and safety of the novel Staphylococcus aureus vaccine V710 in adults with end-stage renal disease receiving hemodialysis. Clin. Vaccin. Immunol. 19, 1509\u20131516 (2012).","journal-title":"Clin. Vaccin. Immunol."},{"key":"73120_CR86","doi-asserted-by":"publisher","first-page":"731845","DOI":"10.3389\/fimmu.2021.731845","volume":"12","author":"AM Deacy","year":"2021","unstructured":"Deacy, A. M., Gan, S. K. & Derrick, J. P. Superantigen Recognition and Interactions: Functions, Mechanisms and Applications. Front Immunol. 12, 731845 (2021).","journal-title":"Front Immunol."},{"key":"73120_CR87","doi-asserted-by":"crossref","unstructured":"Tuffs S. W. et al. Superantigens promote Staphylococcus aureus bloodstream infection by eliciting pathogenic interferon-gamma production. Proc Natl Acad Sci. USA 119, e2115987119 (2022).","DOI":"10.1073\/pnas.2115987119"},{"key":"73120_CR88","doi-asserted-by":"crossref","unstructured":"Salgado-Pab\u00f3n, W. et al. Superantigens are critical for Staphylococcus aureus Infective endocarditis, sepsis, and acute kidney injury. mBio. 4, e00494\u201313 (2013).","DOI":"10.1128\/mBio.00494-13"},{"key":"73120_CR89","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1093\/infdis\/jiu350","volume":"210","author":"BG Vu","year":"2014","unstructured":"Vu, B. G. et al. Superantigens of Staphylococcus aureus from patients with diabetic foot ulcers. J. Infect. Dis. 210, 1920\u20131927 (2014).","journal-title":"J. Infect. Dis."},{"key":"73120_CR90","doi-asserted-by":"crossref","unstructured":"Nambulli S. et al. Inhalable nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses. Sci. Adv 7, eabh0319 (2021).","DOI":"10.1126\/sciadv.abh0319"},{"key":"73120_CR91","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1128\/AAC.01802-15","volume":"60","author":"L Detalle","year":"2016","unstructured":"Detalle, L. et al. Generation and characterization of ALX-0171, a potent novel therapeutic nanobody for the treatment of respiratory syncytial virus infection. Antimicrob. Agents Chemother. 60, 6\u201313 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"73120_CR92","doi-asserted-by":"publisher","first-page":"4526","DOI":"10.1128\/AAC.00510-15","volume":"59","author":"L Hua","year":"2015","unstructured":"Hua, L. et al. MEDI4893* promotes survival and extends the antibiotic treatment window in a Staphylococcus aureus immunocompromised pneumonia model. Antimicrob. Agents Chemother. 59, 4526\u20134532 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"73120_CR93","doi-asserted-by":"publisher","first-page":"29874","DOI":"10.1074\/jbc.M114.601328","volume":"289","author":"V Oganesyan","year":"2014","unstructured":"Oganesyan, V. et al. Mechanisms of neutralization of a human anti-alpha-toxin antibody. J. Biol. Chem. 289, 29874\u201329880 (2014).","journal-title":"J. Biol. Chem."},{"key":"73120_CR94","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1128\/IAI.02110-14","volume":"82","author":"SX Xu","year":"2014","unstructured":"Xu, S. X. et al. Superantigens subvert the neutrophil response to promote abscess formation and enhance Staphylococcus aureus survival in vivo. Infect. Immun. 82, 3588\u20133598 (2014).","journal-title":"Infect. Immun."},{"key":"73120_CR95","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.1074\/jbc.M110.189068","volume":"286","author":"AKNur-ur Rahman","year":"2011","unstructured":"Rahman, A. K. N. ur-ur et al. The T cell receptor beta-chain second complementarity determining region loop (CDR2beta governs T cell activation and Vbeta specificity by bacterial superantigens. J. Biol. Chem. 286, 4871\u20134881 (2011).","journal-title":"J. Biol. Chem."},{"key":"73120_CR96","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1080\/21505594.2016.1267894","volume":"8","author":"MJ Karau","year":"2017","unstructured":"Karau, M. J. et al. Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus. Virulence 8, 1148\u20131159 (2017).","journal-title":"Virulence"},{"key":"73120_CR97","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1086\/340828","volume":"185","author":"L DaSilva","year":"2002","unstructured":"DaSilva, L. et al. Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines. J. Infect. Dis. 185, 1754\u20131760 (2002).","journal-title":"J. Infect. Dis."},{"key":"73120_CR98","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1128\/IAI.73.4.2452-2460.2005","volume":"73","author":"CJ Roy","year":"2005","unstructured":"Roy, C. J. et al. Human leukocyte antigen-DQ8 transgenic mice: a model to examine the toxicity of aerosolized staphylococcal enterotoxin B. Infect. Immun. 73, 2452\u20132460 (2005).","journal-title":"Infect. Immun."},{"key":"73120_CR99","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/ame2.12331","volume":"6","author":"F Li","year":"2023","unstructured":"Li, F. et al. Characterization of genetic humanized mice with transgenic HLA DP401 or DRA but deficient in endogenous murine MHC class II genes upon Staphylococcus aureus pneumonia. Anim. Model Exp. Med. 6, 585\u2013597 (2023).","journal-title":"Anim. Model Exp. Med"},{"key":"73120_CR100","doi-asserted-by":"crossref","unstructured":"Sharma, H. et al. Toxic shock syndrome toxin 1 evaluation and antibiotic impact in a transgenic model of staphylococcal soft tissue infection. mSphere 4, e00665\u201319 (2019).","DOI":"10.1128\/mSphere.00665-19"},{"key":"73120_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54074-8","volume":"15","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. Staphylococcal superantigens evoke temporary and reversible T cell anergy, but fail to block the development of a bacterium-specific cellular immune response. Nat. Commun. 15, 9872 (2024).","journal-title":"Nat. Commun."},{"key":"73120_CR102","doi-asserted-by":"crossref","unstructured":"Tang, S. et al. Rescue of alveolar wall liquid secretion blocks fatal lung injury due to influenza-staphylococcal coinfection. J. Clin. Investig. 133, e163402 (2023).","DOI":"10.1172\/JCI163402"},{"key":"73120_CR103","doi-asserted-by":"publisher","first-page":"e38567","DOI":"10.1371\/journal.pone.0038567","volume":"7","author":"RP Adhikari","year":"2012","unstructured":"Adhikari, R. P. et al. Novel structurally designed vaccine for S. aureus alpha-hemolysin: protection against bacteremia and pneumonia. PLoS ONE 7, e38567 (2012).","journal-title":"PLoS ONE"},{"key":"73120_CR104","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/nm1207-1405","volume":"13","author":"J Bubeck Wardenburg","year":"2007","unstructured":"Bubeck Wardenburg, J., Bae, T., Otto, M., Deleo, F. R. & Schneewind, O. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat. Med. 13, 1405\u20131406 (2007).","journal-title":"Nat. Med."},{"key":"73120_CR105","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/infdis\/jit800","volume":"209","author":"M Wacker","year":"2014","unstructured":"Wacker, M. et al. Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli. J. Infect. Dis. 209, 1551\u20131561 (2014).","journal-title":"J. Infect. Dis."},{"key":"73120_CR106","doi-asserted-by":"crossref","unstructured":"Kleinhenz, M. et al., Toxin-neutralizing Abs are associated with improved T cell function following recovery from Staphylococcus aureus infection. JCI Insight 9, e173526 (2024).","DOI":"10.1172\/jci.insight.173526"},{"key":"73120_CR107","doi-asserted-by":"publisher","first-page":"6147","DOI":"10.1128\/AAC.01285-13","volume":"57","author":"GJ Robbie","year":"2013","unstructured":"Robbie, G. J. et al. A novel investigational Fc-modified humanized monoclonal antibody, motavizumab-YTE, has an extended half-life in healthy adults. Antimicrob. Agents Chemother. 57, 6147\u20136153 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"73120_CR108","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1128\/IAI.01313-06","volume":"75","author":"JBubeck Wardenburg","year":"2007","unstructured":"Wardenburg, J. B. ubeck, Patel, R. J. & Schneewind, O. Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect. Immun. 75, 1040\u20131044 (2007).","journal-title":"Infect. Immun."},{"key":"73120_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103014","volume":"24","author":"Z Shen","year":"2021","unstructured":"Shen, Z. et al. A resource of high-quality and versatile nanobodies for drug delivery. iScience 24, 103014 (2021).","journal-title":"iScience"},{"key":"73120_CR110","doi-asserted-by":"publisher","first-page":"705360","DOI":"10.3389\/fimmu.2021.705360","volume":"12","author":"J Clegg","year":"2021","unstructured":"Clegg, J. et al. Staphylococcus aureus vaccine research and development: the past, present and future, including novel therapeutic strategies. Front Immunol. 12, 705360 (2021).","journal-title":"Front Immunol."},{"key":"73120_CR111","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6981095","volume":"2020","author":"HM Elsherif","year":"2020","unstructured":"Elsherif, H. M. et al. Staphylococcal enterotoxins and toxic shock syndrome toxin-1 and their association among bacteremic and infective endocarditis patients in egypt. Biomed. Res. Int. 2020, 6981095 (2020).","journal-title":"Biomed. Res. Int."},{"key":"73120_CR112","doi-asserted-by":"crossref","unstructured":"Fischer, A. J. et al. High prevalence of Staphylococcus aureus enterotoxin gene cluster superantigens in cystic fibrosis clinical isolates. Genes. 10, 1036 (2019).","DOI":"10.3390\/genes10121036"},{"key":"73120_CR113","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1086\/432798","volume":"41","author":"T Ferry","year":"2005","unstructured":"Ferry, T. et al. Comparative prevalence of superantigen genes in Staphylococcus aureus isolates causing sepsis with and without septic shock. Clin. Infect. Dis. 41, 771\u2013777 (2005).","journal-title":"Clin. Infect. Dis."},{"key":"73120_CR114","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s10096-003-0928-0","volume":"22","author":"M Mempel","year":"2003","unstructured":"Mempel, M. et al. High prevalence of superantigens associated with the egc locus in Staphylococcus aureus isolates from patients with atopic eczema. Eur. J. Clin. Microbiol. Infect. Dis. 22, 306\u2013309 (2003).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"73120_CR115","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1128\/JCM.41.4.1434-1439.2003","volume":"41","author":"K Becker","year":"2003","unstructured":"Becker, K. et al. Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens. J. Clin. Microbiol. 41, 1434\u20131439 (2003).","journal-title":"J. Clin. Microbiol."},{"key":"73120_CR116","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1099\/jmm.0.2008\/002790-0","volume":"57","author":"DL Hu","year":"2008","unstructured":"Hu, D. L. et al. Comparative prevalence of superantigenic toxin genes in meticillin-resistant and meticillin-susceptible Staphylococcus aureus isolates. J. Med. Microbiol. 57, 1106\u20131112 (2008).","journal-title":"J. Med. Microbiol."},{"key":"73120_CR117","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12866-021-02319-7","volume":"21","author":"E Abbasi Montazeri","year":"2021","unstructured":"Abbasi Montazeri, E., Khosravi, A. D., Khazaei, S. & Sabbagh, A. Prevalence of methicillin resistance and superantigenic toxins in Staphylococcus aureus strains isolated from patients with cancer. BMC Microbiol. 21, 262 (2021).","journal-title":"BMC Microbiol"},{"key":"73120_CR118","doi-asserted-by":"crossref","unstructured":"Merriman, J. A. et al. Temporal and racial differences associated with atopic dermatitis, Staphylococcus aureus and encoded virulence factors. mSphere 1, e00295\u201316 (2016).","DOI":"10.1128\/mSphere.00295-16"},{"key":"73120_CR119","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-019-4166-7","volume":"12","author":"H Tahmasebi","year":"2019","unstructured":"Tahmasebi, H., Dehbashi, S. & Arabestani, M. R. Association between the accessory gene regulator (agr) locus and the presence of superantigen genes in clinical isolates of methicillin-resistant Staphylococcus aureus. BMC Res. Notes 12, 130 (2019).","journal-title":"BMC Res. Notes"},{"key":"73120_CR120","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.diagmicrobio.2014.11.007","volume":"81","author":"CK Kim","year":"2015","unstructured":"Kim, C. K. et al. Superantigens in Staphylococcus aureus isolated from prosthetic joint infection. Diagn. Microbiol Infect. Dis. 81, 201\u2013207 (2015).","journal-title":"Diagn. Microbiol Infect. Dis."},{"key":"73120_CR121","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s10096-009-0752-2","volume":"28","author":"S Monecke","year":"2009","unstructured":"Monecke, S., Luedicke, C., Slickers, P. & Ehricht, R. Molecular epidemiology of Staphylococcus aureus in asymptomatic carriers. Eur. J. Clin. Microbiol Infect. Dis. 28, 1159\u20131165 (2009).","journal-title":"Eur. J. Clin. Microbiol Infect. Dis."},{"key":"73120_CR122","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ijfoodmicro.2005.10.013","volume":"108","author":"J Bania","year":"2006","unstructured":"Bania, J. et al. Distribution of newly described enterotoxin-like genes in Staphylococcus aureus from food. Int J. Food Microbiol. 108, 36\u201341 (2006).","journal-title":"Int J. Food Microbiol"},{"key":"73120_CR123","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1365-2133.2009.09038.x","volume":"160","author":"LS Chiu","year":"2009","unstructured":"Chiu, L. S., Ho, M. S., Hsu, L. Y. & Tang, M. B. Prevalence and molecular characteristics of Staphylococcus aureus isolates colonizing patients with atopic dermatitis and their close contacts in Singapore. Br. J. Dermatol 160, 965\u2013971 (2009).","journal-title":"Br. J. Dermatol"},{"key":"73120_CR124","doi-asserted-by":"publisher","first-page":"e1002271","DOI":"10.1371\/journal.ppat.1002271","volume":"7","author":"GJ Wilson","year":"2011","unstructured":"Wilson, G. J. et al. A novel core genome-encoded superantigen contributes to lethality of community-associated MRSA necrotizing pneumonia. PLoS Pathog. 7, e1002271 (2011).","journal-title":"PLoS Pathog."},{"key":"73120_CR125","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jim.2014.04.007","volume":"410","author":"HK Kim","year":"2014","unstructured":"Kim, H. K., Missiakas, D. & Schneewind, O. Mouse models for infectious diseases caused by Staphylococcus aureus. J. Immunol. Methods 410, 88\u201399 (2014).","journal-title":"J. Immunol. Methods"},{"key":"73120_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52714-7","volume":"15","author":"KL Tomaszewski","year":"2024","unstructured":"Tomaszewski, K. L. et al. Enhanced Staphylococcus aureus protection by uncoupling of the alpha-toxin-ADAM10 interaction during murine neonatal vaccination. Nat. Commun. 15, 8702 (2024).","journal-title":"Nat. Commun."},{"key":"73120_CR127","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1086\/656043","volume":"202","author":"AD Kennedy","year":"2010","unstructured":"Kennedy, A. D. et al. Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J. Infect. Dis. 202, 1050\u20131058 (2010).","journal-title":"J. Infect. Dis."},{"key":"73120_CR128","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/cid\/cit123","volume":"56","author":"SA Fritz","year":"2013","unstructured":"Fritz, S. A. et al. A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection. Clin. Infect. Dis. 56, 1554\u20131561 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"73120_CR129","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-1-4939-3344-0_7","volume":"1396","author":"KL Strandberg","year":"2016","unstructured":"Strandberg, K. L., Rotschafer, J. H. & Schlievert, P. M. Rabbit Model for Superantigen-Mediated Lethal Pulmonary Disease. Methods Mol. Biol. 1396, 81\u201393 (2016).","journal-title":"Methods Mol. Biol."},{"key":"73120_CR130","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fcimb.2012.00018","volume":"2","author":"AR Spaulding","year":"2012","unstructured":"Spaulding, A. R. et al. Comparison of Staphylococcus aureus strains for ability to cause infective endocarditis and lethal sepsis in rabbits. Front Cell Infect. Microbiol. 2, 18 (2012).","journal-title":"Front Cell Infect. Microbiol"},{"key":"73120_CR131","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0966-842X(01)02078-9","volume":"9","author":"A Tarkowski","year":"2001","unstructured":"Tarkowski, A. et al. Model systems: modeling human staphylococcal arthritis and sepsis in the mouse. Trends Microbiol. 9, 321\u2013326 (2001).","journal-title":"Trends Microbiol"},{"key":"73120_CR132","doi-asserted-by":"crossref","unstructured":"Mrochen, D. M., Fernandes de Oliveira, L. M., Raafat, D., Holtfreter, S. Staphylococcus aureus host tropism and its implications for murine infection models. Int J Mol Sci. 21, 7061 (2020).","DOI":"10.3390\/ijms21197061"},{"key":"73120_CR133","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrmicro3308","volume":"12","author":"W Salgado-Pabon","year":"2014","unstructured":"Salgado-Pabon, W. & Schlievert, P. M. Models matter: the search for an effective Staphylococcus aureus vaccine. Nat. Rev. Microbiol. 12, 585\u2013591 (2014).","journal-title":"Nat. Rev. Microbiol"},{"key":"73120_CR134","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3389\/fimmu.2017.00512","volume":"8","author":"D Parker","year":"2017","unstructured":"Parker, D. Humanized mouse models of Staphylococcus aureus infection. Front Immunol. 8, 512 (2017).","journal-title":"Front Immunol."},{"key":"73120_CR135","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fcimb.2012.00016","volume":"2","author":"F Bagnoli","year":"2012","unstructured":"Bagnoli, F., Bertholet, S. & Grandi, G. Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials. Front Cell Infect. Microbiol. 2, 16 (2012).","journal-title":"Front Cell Infect. Microbiol"},{"key":"73120_CR136","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nprot.2014.039","volume":"9","author":"E Pardon","year":"2014","unstructured":"Pardon, E. et al. A general protocol for the generation of Nanobodies for structural biology. Nat. Protoc. 9, 674\u2013693 (2014).","journal-title":"Nat. Protoc."},{"key":"73120_CR137","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0014-5793(97)01062-4","volume":"414","author":"M Arbabi Ghahroudi","year":"1997","unstructured":"Arbabi Ghahroudi, M., Desmyter, A., Wyns, L., Hamers, R. & Muyldermans, S. Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett. 414, 521\u2013526 (1997).","journal-title":"FEBS Lett."},{"key":"73120_CR138","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr D. Struct. Biol. 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr D. Struct. Biol."},{"key":"73120_CR139","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1107\/S2059798318005119","volume":"74","author":"P Emsley","year":"2018","unstructured":"Emsley, P. & Crispin, M. Structural analysis of glycoproteins: building N-linked glycans with Coot. Acta Crystallogr D. Struct. Biol. 74, 256\u2013263 (2018).","journal-title":"Acta Crystallogr D. Struct. Biol."},{"key":"73120_CR140","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1107\/S2059798316019276","volume":"73","author":"R Fernandez-Leiro","year":"2017","unstructured":"Fernandez-Leiro, R. & Scheres, S. H. W. A pipeline approach to single-particle processing in RELION. Acta Crystallogr D. Struct. Biol. 73, 496\u2013502 (2017).","journal-title":"Acta Crystallogr D. Struct. Biol."},{"key":"73120_CR141","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"73120_CR142","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"73120_CR143","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41592-020-00990-8","volume":"17","author":"A Punjani","year":"2020","unstructured":"Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214\u20131221 (2020).","journal-title":"Nat. Methods"},{"key":"73120_CR144","doi-asserted-by":"crossref","unstructured":"Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife 7, e42166 (2018).","DOI":"10.7554\/eLife.42166"},{"key":"73120_CR145","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.3390\/toxins7051821","volume":"7","author":"SX Xu","year":"2015","unstructured":"Xu, S. X., Kasper, K. J., Zeppa, J. J. & McCormick, J. K. Superantigens modulate bacterial density during Staphylococcus aureus nasal colonization. Toxins 7, 1821\u20131836 (2015).","journal-title":"Toxins"},{"key":"73120_CR146","doi-asserted-by":"crossref","unstructured":"K. Dufresne et al. TSST-1 promotes colonization of Staphylococcus aureus within the vaginal tract by activation of CD8(+) T cells. Infect Immun, 93, e0043924 (2025).","DOI":"10.1128\/iai.00439-24"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73120-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73120-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73120-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T09:03:53Z","timestamp":1779267833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73120-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":146,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73120"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73120-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.J.K. and Y.S. are inventors on a patent application covering several nanobodies evaluated in this study. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4456"}}